| Filed On | Filing |
|---|---|
| 13 Nov 2026 |
Form 4: Rubinstein Julie, President and COO
Received 11,881 shares by exercise or conversion ($144K) · Sold 11,881 shares ($366K) · Received 11,881 shares by exercise or conversion ($144K) · 3 more |
| 13 Nov 2026 |
Form 4: Bobulsky Susan, Chief Commercial Officer, MRD
Sold 1,875 shares ($60K) |
| 12 Nov 2026 |
Form 4: Robins Chad M, Director
Gave 100,000 shares as a gift |
| 12 Nov 2026 | 144 |
| 12 Nov 2026 | 144 |
| 10 Nov 2026 |
Form 4: Rubinstein Julie, President and COO
Received 11,881 shares by exercise or conversion ($144K) · Sold 11,881 shares ($358K) · Received 11,881 shares by exercise or conversion ($144K) · 1 more |
| 06 Nov 2026 |
Form 4: Rubinstein Julie, President and COO
Received 11,881 shares by exercise or conversion ($144K) · Sold 11,881 shares ($313K) · Received 11,881 shares by exercise or conversion ($144K) · 3 more |
| 04 Nov 2026 | 10-Q |
| 04 Nov 2026 |
8-K: Results of Operations and Financial Condition
SEATTLE, Nov. 04, 2026 (GLOBE NEWSWIRE) – Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”) (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into c... |
| 03 Nov 2026 |
Form 4: Rubinstein Julie, President and COO
Received 11,881 shares by exercise or conversion ($144K) · Sold 11,881 shares ($318K) · Received 11,881 shares by exercise or conversion ($144K) · 3 more |
| 29 Oct 2026 |
Form 4: Rubinstein Julie, President and COO
Received 11,881 shares by exercise or conversion ($144K) · Sold 11,881 shares ($324K) · Received 11,881 shares by exercise or conversion ($144K) · 3 more |
| 26 Oct 2026 |
Form 4: Rubinstein Julie, President and COO
Received 11,881 shares by exercise or conversion ($144K) · Sold 11,881 shares ($291K) · Received 11,881 shares by exercise or conversion ($144K) · 3 more |
| 21 Oct 2026 |
Form 4: Rubinstein Julie, President and COO
Received 11,881 shares by exercise or conversion ($144K) · Sold 11,881 shares ($286K) · Received 11,881 shares by exercise or conversion ($144K) · 3 more |
| 16 Oct 2026 |
Form 4: Rubinstein Julie, President and COO
Received 11,881 shares by exercise or conversion ($144K) · Sold 11,881 shares ($305K) · Received 11,881 shares by exercise or conversion ($144K) · 3 more |
| 13 Oct 2026 |
Form 4: Rubinstein Julie, President and COO
Received 11,881 shares by exercise or conversion ($144K) · Sold 11,881 shares ($314K) · Received 11,881 shares by exercise or conversion ($144K) · 3 more |
| 08 Oct 2026 |
Form 4: Rubinstein Julie, President and COO
Received 11,881 shares by exercise or conversion ($144K) · Sold 11,881 shares ($330K) · Received 11,881 shares by exercise or conversion ($144K) · 3 more |
| 08 Oct 2026 |
Form 4: Bobulsky Susan, Chief Commercial Officer, MRD
Sold 6,444 shares ($193K) |
| 06 Oct 2026 | 144 |
| 05 Oct 2026 |
Form 4: Rubinstein Julie, President and COO
Received 11,881 shares by exercise or conversion ($144K) · Sold 11,881 shares ($333K) · Received 11,881 shares by exercise or conversion ($144K) · 3 more |
| 05 Oct 2026 |
Form 4: Lo Francis, Chief People Officer
Received 26,792 shares by exercise or conversion ($182K) · Sold 26,792 shares ($758K) |
Loading...